SCHEMBL28215645

SCHEMBL28215645

N#Cc1cccc2cc(C3CC3)[nH]c12

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CUL4A Q13619 1/20 0.37
▸ KDM4E B2RXH2 3/20 0.36
▸ ALDH1A1 P00352 3/20 0.36
▸ GLA P06280 1/20 0.36
▸ POLB P06746 1/20 0.36
▸ GAA P10253 1/20 0.36
▸ HPGD P15428 1/20 0.36
▸ HSD17B10 Q99714 1/20 0.36
▸ BCAT1 P54687 1/20 0.35
▸ DYRK1A Q13627 3/20 0.35
▸ CLK1 P49759 1/20 0.35
▸ CA1 P00915 1/20 0.34
▸ CA2 P00918 1/20 0.34
▸ SLC6A2 P23975 2/20 0.33
▸ SLC6A4 P31645 2/20 0.33
▸ SMN1; SMN2 Q16637 1/20 0.33
▸ SLC6A3 Q01959 1/20 0.33
▸ KCNH2 Q12809 1/20 0.33
▸ KDM5A P29375 1/20 0.33
▸ KDM5B Q9UGL1 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15558979 0.74 CUL4A (0.40) CUL4AKDM4EALDH1A1GLAPOLB
SCHEMBL12778112 0.74 DYRK1A (0.41) KDM4EALDH1A1GAADYRK1ACLK1
SCHEMBL29361472 0.73 TSHR (0.41) KDM4EALDH1A1POLBGAAHPGD
SCHEMBL7848657 0.73 NR3C1 (0.38) KDM4EALDH1A1GAABCAT1DYRK1A
SCHEMBL15451009 0.73 TSHR (0.41) KDM4EALDH1A1POLBGAAHPGD
SCHEMBL15971177 0.72 KDM5A (0.40) KDM4EALDH1A1GLAPOLBGAA
SCHEMBL8303053 0.70 NR3C1 (0.42) KDM4EALDH1A1GLAPOLBGAA
SCHEMBL23676495 0.69 DYRK1A (0.36) KDM4EALDH1A1POLBHPGDDYRK1A
SCHEMBL12755314 0.69 NR3C1 (0.39) KDM4EALDH1A1GLAGAAHPGD
SCHEMBL31537986 0.69 CYP2A6 (0.47) KDM4EALDH1A1GAADYRK1ACLK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-105051037-B Sphingosine-1-phosphate receptor agonists, method for the preparation thereof and pharmaceutical compositions comprising the same as active agent LG化学株式会社 2018-05-18 — — CN disclosed
Send feedback